BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/23/2024 4:13:00 AM | Browse: 549 | Download: 1886
Publication Name World Journal of Clinical Oncology
Manuscript ID 88063
Country China
Received
2023-09-08 06:17
Peer-Review Started
2023-09-08 06:19
First Decision by Editorial Office Director
2023-10-17 07:57
Return for Revision
2023-10-17 07:57
Revised
2023-11-20 08:51
Publication Fee Transferred
Editorial Processing by Scientific Editor
2023-12-06 10:29
Final Academic Decision by Editor-in-Chief
Publication Technical Verification by Editorial Office Director
2023-12-19 07:16
Articles in Press
2023-12-19 07:16
Edit the Manuscript by Language Editor
2023-12-24 07:52
Typeset the Manuscript
2024-01-13 12:45
Publish the Manuscript Online
2024-01-23 04:13
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Clinical Neurology
Manuscript Type Translational Research
Article Title Scinderin promotes glioma cell migration and invasion via remodeling actin cytoskeleton
Manuscript Source Unsolicited Manuscript
All Author List Xin Lin, Zhao Zhao, Shu-Peng Sun and Wei Liu
ORCID
Author(s) ORCID Number
Xin Lin http://orcid.org/0000-0003-0597-5942
Funding Agency and Grant Number
Corresponding Author Xin Lin, PhD, Associate Chief Physician, Department of Neurosurgical , Tianjin Huanhu Hospital, No. 6 Jizhao Road, Jinnan District, Tianjin 300000, China. xnln69@aliyun.com
Key Words Glioma; Scinderin; Actin cytoskeleton; RhoA/FAK signaling
Core Tip Actin dynamics-related protein scinderin (SCIN) was found to be significantly upregulated in glioma, and high SCIN expression was associated with increased tumor grade and wild-type isocitrate dehydrogenase. Furthermore, silenced-SCIN cells exhibited repressed proliferation, migration, and invasion. Moreover, knockdown of SCIN inhibited RhoA/focal adhesion kinase signaling to promote F-actin depolymerization in glioma cells.
Publish Date 2024-01-23 04:13
Citation Lin X, Zhao Z, Sun SP, Liu W. Scinderin promotes glioma cell migration and invasion via remodeling actin cytoskeleton. World J Clin Oncol 2024; 15(1): 32-44
URL https://www.wjgnet.com/2218-4333/full/v15/i1/32.htm
DOI https://dx.doi.org/10.5306/wjco.v15.i1.32
Full Article (PDF) WJCO-15-32-with-cover.pdf
Full Article (Word) WJCO-15-32.docx